ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Territory Business Manager at SpringWorks Therapeutics - ApplyBlast

Territory Business Manager

SpringWorks Therapeutics

5 days ago

4.2 on Glassdoor

Remote

Full Time

Manager

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Territory Business Manager leads sales at the territory level as the primary liaison between customers and SpringWorks Therapeutics, delivering on revenue goals through clinical communication and account planning. This role involves building relationships with key healthcare professionals and hospitals while promoting rare disease products in compliance with company and industry guidelines. The position requires strategic adaptation to the evolving healthcare landscape and collaboration with field and headquarters colleagues to support patient access and sales targets.

Responsibilities

Lead sales at the territory level and serve as primary liaison between customers and SpringWorks Therapeutics
Achieve revenue goals by executing brand objectives through communication of approved clinical information
Build relationships with key healthcare professionals, physician practices, and hospitals across various settings

Skills

About SpringWorks Therapeutics

springworkstx.com

Headquarters

Stamford, Connecticut, United States

Company Size

201-500 employees

Founded

2017

View Profile

SpringWorks Therapeutics, a healthcare company of Merck KGaA, Darmstadt, Germany, is a commercial-stage biopharmaceutical company focused on targeted oncology, including rare oncology and BCMA combinations in multiple myeloma. The company develops and commercializes treatments for patients with devastating cancers and rare diseases, with approved medicines including OGSIVEO® (nirogacestat) for desmoid tumors and EZMEKLY® (mirdametinib) for NF1-associated plexiform neurofibromas. SpringWorks combines scientific rigor with a patient-centric, urgency-driven approach to unlock the full potential of targeted oncology.